Novartis is reimagining medicine to improve and extend people’s lives. As a leading global medicines company, we use innovative science and digital technologies to create transformative treatments in areas of great medical need. In our quest to find new medicines, we consistently rank among the world’s top companies investing in research and development. Novartis products reach nearly 800 million people globally and we are finding innovative ways to expand access to our latest treatments. About 110,000 people of more than 140 nationalities work at Novartis around the world.
Recordati Rare Diseases
LINDBERG is the world’s leading independent manufacturer of premium eyewear, famous for its award-winning designs characterised by their distinctive Scandinavian minimalism and a purity of line that gets noticed everywhere.
Eyewear from LINDBERG is remarkable for its lightness, no-compromise attention to detail and exceptional comfort, featuring a unique level of technical finesse, artfully applied technology and exquisite materials.
Metrovision, since 1986: pediatric instruments for retinal imaging (new born and infants), FA, electrophysiology, perimetry, clinical research, psychophysical tests.
Natus is the global brand clinicians depend on when diagnosing and treating disorders of the central nervous and sensory systems to improve patient outcomes. We design each product to deliver practical, accurate and dependable results in a quick and reliable manner. Our products provide the information you need to help improve clinical outcomes for your patients and your staff. We develop and manufacture under trusted brand names, including ALGO®, Echo-Screen®, neoBLUE®, Neometrics®, NICVIEW®, Olympic® and RetCam™.
Topcon Eye Care company provides ophthalmic instruments for examination, diagnosis, treatment as well as optometric instruments for refraction Topcon Denmark is your local contact for sales and service.
Your company logo, a short introduction of your company and a link to your website will appear here if you sponsor EPOS 2021.